Related Experiment Video

Updated: Aug 1, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

[Alzheimer's disease and treatment of vascular risk factors]

F E de Leeuw1, A G W van Norden, W M van der Flier

  • 1Universitair Medisch Centrum St Radboud, Huispostnummer 326, Postbus gIoI, 6500 HB Nijmegen. h.deleeuw@neuro.umcn.nl

Nederlands Tijdschrift Voor Geneeskunde
|January 10, 2006
PubMed

Insights

Vascular risk factors like hypertension and high cholesterol are linked to Alzheimer's disease (AD) risk. Early hypertension treatment may reduce AD risk, but more research is needed for definitive treatment strategies.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Gerontology

Context:

  • Growing evidence links vascular risk factors to Alzheimer's disease (AD) pathogenesis.
  • Hypertension, hypercholesterolemia, hyperhomocysteinemia, and diabetes mellitus are key factors.
  • The interplay between vascular health and neurodegeneration is a critical area of research.

Purpose:

  • To review the current evidence connecting vascular risk factors to Alzheimer's disease (AD).
  • To assess the potential of treating vascular risk factors for AD prevention and management.
  • To identify the need for rigorous, large-scale clinical trials in AD research.

Summary:

  • Vascular risk factors, including hypertension and high cholesterol, are increasingly associated with Alzheimer's disease (AD) risk.
  • Treating hypertension before cognitive decline may lower AD risk. Statins show some cognitive benefits in AD patients.
  • Further research on treating hypertension, hyperhomocysteinemia, and diabetes for AD progression is ongoing, but current findings require cautious interpretation due to study limitations.

Impact:

  • Highlights the significant role of vascular health in Alzheimer's disease (AD) etiology and potential therapeutic interventions.
  • Emphasizes the need for improved diagnostic criteria and robust clinical trial designs for AD research.
  • Suggests that managing vascular risk factors could be a viable strategy for reducing AD incidence and slowing cognitive decline.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 7, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...